3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Obsessive Compulsive Disorder: new trials by email Literature Review of Obsessive Compulsive Disorder trials Research Report on Obsessive Compulsive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder Fluvoxamine maleate, Placebo - Obsessive Compulsive Disorder | Phase 3 | Completed | AbbVie | 38 | 2013-08-14 | 2017-12-04 |
| Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder Cognitive Behavior Therapy, Relaxation Therapy - Obsessive Compulsive Disorder | Phase 3 | Completed | Rhode Island Hospital | 127 | 2007-10-01 | 2013-03-11 |
| Quetiapine Augmentation in Severe Obsessive Compulsive Disorder quetiapine fumarate, SSRI/Clomipramine - Obsessive Compulsive Disorder | Phase 3 | Completed | AstraZeneca | 44 | 2002-04-01 | 2007-12-18 |
Obsessive-Compulsive Disorder (3)
Anxiety Disorders (3) · Mental Disorders (3)
Cognitive Behavioral Therapy (1) · Fluvoxamine (1) · Quetiapine Fumarate (1) · Relaxation Therapy (1)
AbbVie (1) · AstraZeneca (1) · Rhode Island Hospital (1)
Germany (1) · United States (1)
Jennifer B. Freeman, PhD (1) · John S. March, MD (1) · Marty Franklin, PhD (1) · Susumu Matsuki, BS (1)
R01MH079217 (1)